- call +1-201-465-4211
- email sales@mrinsights.biz
Market Overview
The global Biosimilars/Follow-on-Biologics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Biosimilars/Follow-on-Biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biosimilars/Follow-on-Biologics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biosimilars/Follow-on-Biologics market has been segmented into
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
By Application, Biosimilars/Follow-on-Biologics has been segmented into:
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biosimilars/Follow-on-Biologics market presented in the report. This section sheds light on the sales growth of different regional and country-level Biosimilars/Follow-on-Biologics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biosimilars/Follow-on-Biologics market.
The report offers in-depth assessment of the growth and other aspects of the Biosimilars/Follow-on-Biologics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Biosimilars/Follow-on-Biologics Market Share Analysis
Biosimilars/Follow-on-Biologics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biosimilars/Follow-on-Biologics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biosimilars/Follow-on-Biologics sales, revenue and market share for each player covered in this report.
The major players covered in Biosimilars/Follow-on-Biologics are:
Novartis
Merck Group
LG Life Sciences
Synthon Pharmaceuticals
Hospira
Teva Pharmaceutical Industries
Genentech (Roche Group)
Biocon
Celltrion
Biogen idec, Inc.
Among other players domestic and global, Biosimilars/Follow-on-Biologics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosimilars/Follow-on-Biologics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilars/Follow-on-Biologics, with price, sales, revenue and global market share of Biosimilars/Follow-on-Biologics in 2018 and 2019.
Chapter 3, the Biosimilars/Follow-on-Biologics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilars/Follow-on-Biologics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biosimilars/Follow-on-Biologics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biosimilars/Follow-on-Biologics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Biosimilars/Follow-on-Biologics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biosimilars/Follow-on-Biologics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Human growth hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.2.8 Peptide
1.2.9 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Biosimilars/Follow-on-Biologics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Blood disorders
1.3.3 Oncology diseases
1.3.4 Chronic and autoimmune diseases
1.3.5 Growth hormone deficiencies
1.3.6 Others
1.4 Overview of Global Biosimilars/Follow-on-Biologics Market
1.4.1 Global Biosimilars/Follow-on-Biologics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck Group
2.2.1 Merck Group Details
2.2.2 Merck Group Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck Group SWOT Analysis
2.2.4 Merck Group Product and Services
2.2.5 Merck Group Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 LG Life Sciences
2.3.1 LG Life Sciences Details
2.3.2 LG Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 LG Life Sciences SWOT Analysis
2.3.4 LG Life Sciences Product and Services
2.3.5 LG Life Sciences Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Synthon Pharmaceuticals
2.4.1 Synthon Pharmaceuticals Details
2.4.2 Synthon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Synthon Pharmaceuticals SWOT Analysis
2.4.4 Synthon Pharmaceuticals Product and Services
2.4.5 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hospira
2.5.1 Hospira Details
2.5.2 Hospira Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hospira SWOT Analysis
2.5.4 Hospira Product and Services
2.5.5 Hospira Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pharmaceutical Industries
2.6.1 Teva Pharmaceutical Industries Details
2.6.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva Pharmaceutical Industries SWOT Analysis
2.6.4 Teva Pharmaceutical Industries Product and Services
2.6.5 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Genentech (Roche Group)
2.7.1 Genentech (Roche Group) Details
2.7.2 Genentech (Roche Group) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Genentech (Roche Group) SWOT Analysis
2.7.4 Genentech (Roche Group) Product and Services
2.7.5 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Biocon
2.8.1 Biocon Details
2.8.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Biocon SWOT Analysis
2.8.4 Biocon Product and Services
2.8.5 Biocon Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Celltrion
2.9.1 Celltrion Details
2.9.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Celltrion SWOT Analysis
2.9.4 Celltrion Product and Services
2.9.5 Celltrion Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Biogen idec, Inc.
2.10.1 Biogen idec, Inc. Details
2.10.2 Biogen idec, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Biogen idec, Inc. SWOT Analysis
2.10.4 Biogen idec, Inc. Product and Services
2.10.5 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biosimilars/Follow-on-Biologics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biosimilars/Follow-on-Biologics Manufacturer Market Share in 2019
3.3.2 Top 6 Biosimilars/Follow-on-Biologics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biosimilars/Follow-on-Biologics Sales, Revenue and Market Share by Regions
4.1.1 Global Biosimilars/Follow-on-Biologics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Regions (2015-2020)
4.2 North America Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
4.3 Europe Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
4.5 South America Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biosimilars/Follow-on-Biologics Sales, Revenue and Market Share by Country
5.1.1 North America Biosimilars/Follow-on-Biologics Sales and Market Share by Country (2015-2020)
5.1.2 North America Biosimilars/Follow-on-Biologics Revenue and Market Share by Country (2015-2020)
5.2 United States Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
5.3 Canada Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
5.4 Mexico Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biosimilars/Follow-on-Biologics Sales, Revenue and Market Share by Country
6.1.1 Europe Biosimilars/Follow-on-Biologics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biosimilars/Follow-on-Biologics Revenue and Market Share by Country (2015-2020)
6.2 Germany Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
6.3 UK Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
6.4 France Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
6.5 Russia Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
6.6 Italy Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biosimilars/Follow-on-Biologics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biosimilars/Follow-on-Biologics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biosimilars/Follow-on-Biologics Revenue and Market Share by Regions (2015-2020)
7.2 China Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
7.3 Japan Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
7.4 Korea Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
7.5 India Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
7.7 Australia Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biosimilars/Follow-on-Biologics Sales, Revenue and Market Share by Country
8.1.1 South America Biosimilars/Follow-on-Biologics Sales and Market Share by Country (2015-2020)
8.1.2 South America Biosimilars/Follow-on-Biologics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
8.3 Argentina Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biosimilars/Follow-on-Biologics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biosimilars/Follow-on-Biologics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biosimilars/Follow-on-Biologics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
9.3 Turkey Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
9.4 Egypt Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
9.5 South Africa Biosimilars/Follow-on-Biologics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biosimilars/Follow-on-Biologics Sales and Market Share by Type (2015-2020)
10.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Type (2015-2020)
10.3 Global Biosimilars/Follow-on-Biologics Price by Type (2015-2020)
11 Global Biosimilars/Follow-on-Biologics Market Segment by Application
11.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2015-2020)
11.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application (2015-2020)
11.3 Global Biosimilars/Follow-on-Biologics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biosimilars/Follow-on-Biologics Sales, Revenue and Growth Rate (2021-2025)
12.2 Biosimilars/Follow-on-Biologics Market Forecast by Regions (2021-2025)
12.2.1 North America Biosimilars/Follow-on-Biologics Market Forecast (2021-2025)
12.2.2 Europe Biosimilars/Follow-on-Biologics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biosimilars/Follow-on-Biologics Market Forecast (2021-2025)
12.2.4 South America Biosimilars/Follow-on-Biologics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biosimilars/Follow-on-Biologics Market Forecast (2021-2025)
12.3 Biosimilars/Follow-on-Biologics Market Forecast by Type (2021-2025)
12.3.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Type (2021-2025)
12.3.2 Global Biosimilars/Follow-on-Biologics Market Share Forecast by Type (2021-2025)
12.4 Biosimilars/Follow-on-Biologics Market Forecast by Application (2021-2025)
12.4.1 Global Biosimilars/Follow-on-Biologics Sales Forecast by Application (2021-2025)
12.4.2 Global Biosimilars/Follow-on-Biologics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
List of Tables
Table 1. Global Biosimilars/Follow-on-Biologics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biosimilars/Follow-on-Biologics by Company Type (Tier 1, Tier 2 and
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
